Stay updated on Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now indicates that recruitment has ended. It also adds new user-guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision label to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T05:01:05.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.5.4 to v3.5.5, indicating a minor update to the page or document template. This change does not modify the study details or other substantive content on the page.
    Difference
    0.1%
    Check dated 2026-06-07T00:32:37.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.5.3 to v3.5.4, indicating a minor backend update. No clinical trial information or user-facing content is affected.
    Difference
    0.1%
    Check dated 2026-05-16T09:26:19.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    ClinicalTrials.gov updated the page’s software/version revision marker from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T05:28:54.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:49:08.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added the condition 'Inflammatory breast carcinoma' and the Genetic and Rare Diseases Information Center as a resources link. Updated revision labels from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-20T02:05:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Breast Cancer Clinical Trial page.